+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Selective removal of tumor cells from bone marrow by lymphokine activated killer lak cells



Selective removal of tumor cells from bone marrow by lymphokine activated killer lak cells



Proceedings of the American Association for Cancer Research Annual Meeting 28: 371




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029138023

Download citation: RISBibTeXText


Related references

Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. Cellular Immunology 118(2): 448-457, 1989

Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro. Blood 74(1): 354-360, 1989

Elimination of tumor cells from human bone marrow by lymphokine activated killer cells. Clinical Research 35(3): 660A, 1987

Usefulness of lymphokine-activated killer cells generated from bone marrow mononuclear cells for the purging of residual tumor cells in peripheral blood stem cell graft. Japanese Journal of Cancer Research 87(2): 161-169, 1996

Lymphokine-activated killer cell lysis of human neuroblastoma cells: a model for purging tumor cells from bone marrow. Clinical Immunology and Immunopathology 46(1): 150-156, 1988

Lymphokine activated killer cells in mouse bone marrow chimeras the relationship to natural killer cells and to alloreactive cytotoxic t cells. Scandinavian Journal of Immunology 22(5): 479-488, 1985

Use of lymphokine activated killer cells to purge tumor contaminated bone marrow grafts. Clinical Research 37(4): 915A, 1989

Purging of tumor contaminated human bone marrow utilizing autologous lymphokine activated killer cells. Clinical Research 35(3): 523A, 1987

Lymphokine activated killer cells in rats use as a novel method for cleansing bone marrow of residual tumor for autotransplantation. Federation Proceedings 46(4): 1500, 1987

Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow. Journal of Immunology 137(8): 2425-2427, 1986

The anti tumor efficacy of lymphokine activated killer cells and recombinant interleukin 2 in vivo direct correlation between reduction of established metastases and cytolytic activity of lymphokine activated killer cells. Journal of Immunology 136(10): 3899-3909, 1986

Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells. Neurosurgery 31(3): 534-540, 1992

Use of lymphokine activated killer lak cells to prevent rejection of transplanted bone marrow stem cells. Journal of Cellular Biochemistry Supplement (12 PART C): 101, 1988

Influence of cytokines and autologous lymphokine-activated killer cells on leukemic bone marrow cells and colonies in AML. Acta Haematologica 105(4): 209-221, 2001

Lymphokine-activated killer and Bacillus Calmette-Guerin-activated killer cells Two ways of activation of cytotoxic effector cells against bladder tumor cells in vitro. European Journal of Cell Biology 63(SUPPL 40): 74, 1994